´ëÇÑ°©»ó¼±ÇÐȸ 2022 Ãá°èÇмú´ëȸ°¡ 2022³â 3¿ù 4ÀÏ(±Ý)¿¡¼ 5ÀÏ(Åä)±îÁö ¾çÀÏ°£ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ (BPEX)¿¡¼ °³ÃֵǾú´Ù. ¿ì¸® ÇÐȸ´Â COVID-19 »óȲ¿¡ À¯¿¬ÇÏ°Ô ´ëóÇÏ¿© ÇÏÀ̺긮µå Çü½ÄÀÇ ¿Â, ¿ÀÇÁ¶óÀÎ ½ÉÆ÷Áö¾öÀ» ¼±µµÇØ¿Â ¸¸Å ¿øÈ°ÇÑ ÁøÇàÀ¸·Î ÃֽŠ°©»ó¼± À̽´¿¡ ´ëÇÑ Á¤º¸ ±³·ù¿Í ȸ¿øµé °£ÀÇ È°¹ßÇÑ Åä·Ð°ú Ä£¸ñÀÇ ½Ã°£ÀÌ µÉ ¼ö ÀÖ¾ú´Ù.
Çмú´ëȸ ÇÁ·Î±×·¥Àº ºÐ¾ßº° 5°³ÀÇ ¸ÞÀÎ ½ÉÆ÷Áö¾ö°ú 2°³ÀÇ education ¼¼¼Ç, special lecture·Î ±¸¼ºµÇ¾î ±¹³»¿Ü Àü¹®°¡µéÀÇ ÃֽŠ½Ä°ß°ú °¿¬ ÀÌÈÄ À̾îÁö´Â È°¹ßÇÑ ¿Â, ¿ÀÇÁ¶óÀÎ Åä·ÐÀ¸·Î ÇÐȸ ±â°£ ³»³» ¿¶í ºÐÀ§±â¸¦ À̾´Ù.
¿ÃÇØ ¹ü»êÇмú»óÀº °æºÏÀÇ´ë ÇÙÀÇÇаú ÀÌÀçÅ ±³¼ö°¡ ¼ö»óÇÏ¿´À¸¸ç ¡°¹æ»ç¼º¿ä¿ÀµåÄ¡·á¿Í 2Â÷¾Ï¡±À̶ó´Â ÁÖÁ¦·Î ¼ö»ó °¿¬ÀÌ ÁøÇàµÇ¾ú´Ù. Toronto general hospitalÀÇ Ozgur Mete ±³¼öÀÇ °©»ó¼±¾ÏÀÇ º´¸®ÇÐÀû ¿¹ÈÄ ÁöÇ¥¿¡ ´ëÇÑ Ç÷¹³Ê¸® °¿¬ÀÌ ÀÖ¾úÀ¸¸ç ¿¬¼¼ÀÇ´ë À̺ñÀÎÈÄ°ú °íÀ±¿ì ±³¼ö¿Í Peking Union Medical College HospitalÀÇ Yansong Lin ±³¼ö°¡ MTP ¼¼¼Ç¿¡¼ °¿¬ÇÏ¿´´Ù. Special lecture¿¡¼´Â °©»ó¼±Áúȯ¿¡¼ ¼¿·¹´Ï¿òÀÇ ¿ªÇÒ¿¡ ´ëÇÏ¿© ÇØ´ç ºÐ¾ßÀÇ ±ÇÀ§ÀÚÀÎ Lutz Schomburg ±³¼ö°¡ ÀÚ°¡¸é¿ª¼º °©»ó¼±ÁúȯÀÇ biomarker·Î¼ selenoprotein PÀÇ ¿ªÇÒ¿¡ ´ëÇÏ¿© °¿¬ÇÏ¿´´Ù.
ƯÈ÷ À̹ø ÇÐȸ¿¡¼´Â active surveillance¿Í °ü·ÃµÈ ±¹³» ´Ù±â°ü ÀÓ»ó ¿¬±¸ °á°úµéÀÌ °ø°³µÇ¾î ¸¹Àº ȸ¿øµéÀÇ °ü½ÉÀ» ²ø¾ú´Ù. °©»ó¼±À¯µÎ¾ÏÀÇ ´Éµ¿ °¨½Ã¿Í °ü·ÃÇÏ¿© ±¹³»¿¡¼ ÁøÇàµÇ°í ÀÖ´Â ´Ù±â°ü ¿¬±¸µéÀÌ ¼Ò°³µÇ¾úÀ¸¸ç ƯÈ÷ ´Éµ¿ °¨½Ã ´ë»ó ȯÀÚµéÀÇ TSH ¼öÄ¡ ¹× tumor volume doubling time¿¡ ´ëÇÑ µ¥ÀÌÅÍ°¡ ¼Ò°³µÇ¾î ´Éµ¿ °¨½Ã Àû¿ë ½Ã ÀûÀýÇÑ TSH ¼öÄ¡ À¯ÁöÀÇ Çʿ伺°ú ¿¹ÈÄ ¿¹Ãø ÁöÇ¥·Î¼ tumor volume doubling timeÀÇ ÀÓ»óÀû Àǹ̿¡ ´ëÇÑ Á¦¾È°ú ÇØ´ç °á°ú¿¡ ´ëÇÑ ´Ù¾çÇÑ ÀÇ°ß °³ÁøÀÌ ÀÖ¾ú´Ù. ÇöÀç °©»ó¼±À¯µÎ¾Ï¿¡ ´ëÇÑ ´Éµ¿ °¨½Ã¿Í °ü·ÃÇÏ¿© ±¹³»¿¡¼ ÁøÇàµÇ°í ÀÖ´Â ´ë±Ô¸ð ´Ù±â°ü ÀüÇâÀû ÄÚȣƮ ¿¬±¸ÀÎ KoMPASS, MAeSTro µÎ °¡Áö ¿¬±¸°¡ ¼Ò°³µÇ°í Èï¹Ì·Î¿î Áß°£ ºÐ¼® °á°ú°¡ °øÀ¯µÇ¾ú´Ù. ƯÈ÷ ´ÙÇÐÁ¦ ÇÐȸÀÇ Æ¯¼º »ó °¢ ºÐ¾ßÀÇ °üÁ¡À¸·Î ´Éµ¿ °¨½Ã¶ó´Â ÃֽŠÀ̽´¿¡ ´ëÇÑ ¿©·¯°¡Áö ÀÇ°ßµéÀÌ ÇöÀå°¨ÀÖ°Ô ±³·ùµÇ¾ú´Ù´Â µ¥¿¡ Å« Àǹ̰¡ ÀÖ¾ú´Ù.
Education ¼¼¼Ç¿¡¼´Â °©»ó¼±À¯µÎ¾Ï, ¿©Æ÷¾Ï ¹× °ø°ÝÀûÀÎ °©»ó¼±¾ÏÀÇ º´¸®ÇÐÀû ¼Ò°ß°ú 2021³â °³Á¤µÈ K-TIRADS¿Í Thyroid CT ¹× ÇÙÀÇÇÐ ¿µ»ó¿¡ ´ëÇÑ Àü¹®°¡ °ÀÇ°¡ ÁøÇàµÇ¾ú´Ù. ¶ÇÇÑ ±×µ¿¾È Àß ´Ù·ç¾îÁöÁö ¾Ê¾Ò´ø ºÎ°©»ó¼±Áúȯ¿¡ ´ëÇÑ ½Éµµ ÀÖ´Â ½ÉÆ÷Áö¾öÀÌ ±¸¼ºµÇ¾î ¸¹Àº °ü½ÉÀ» ²ø¾ú´Ù. ÀÏÂ÷¼º, ÀÌÂ÷¼º, »ïÂ÷¼º ºÎ°©»ó¼±±â´ÉÇ×ÁøÁõ¿¡¼ÀÇ ¼ö¼ú ÀûÀÀÁõ ¹× ¿µ»ó ¼Ò°ß, ¼ö¼úÀû Ä¡·á¿¡ ´ëÇÏ¿© ½ÅÀå³»°ú, ¿µ»óÀÇÇаú, ¿Ü°ú¸¦ Æ÷ÇÔÇÏ¿© ´Ù¾çÇÑ ºÐ°ú Àü¹®°¡µéÀÌ ¸ð¿© ÃֽŠÁö°ßÀ» °øÀ¯ÇÏ°í Åä·ÐÇÏ´Â ±âȸ°¡ µÇ¾ú´Ù.
À̹ø ÇÐȸ¿¡¼´Â °©»ó¼±ÁúȯÀÇ Áø´Ü°ú °ü¸®¿¡ ÀÖ¾î ¹Ì·¡¸¦ Àü¸ÁÇغ¼ ¼ö ÀÖ´Â Çõ½ÅÀûÀÎ ÁÖÁ¦ÀÇ ¼¼¼Çµµ À̾îÁ³´Ù. ¿ªÇü¼º¾Ï À§Çèµµ ¿¹Ãø ÁöÇ¥·Î¼ CREB3L1ÀÇ ¿ªÇÒ¿¡ ´ëÇÏ¿© ¼Ò°³µÇ¾úÀ¸¸ç ¿þ¾î·¯ºí ±â±â¿¡ ±â¹ÝÇÑ °©»ó¼±Áúȯ ÀÚ°¡ °ü¸® ¸ð¹ÙÀÏ ¾Û°ú °©»ó¼±¾Ï Áø´Ü¿¡ È°¿ë °¡´ÉÇÑ ÀΰøÁö´É (AI) ±â¹Ý CAD systemÀÌ ¼Ò°³µÇ¾ú´Ù. ¶ÇÇÑ °æºÎ ÃÊÀ½ÆÄ ±Þ¿© È®´ë¿Í ¼ö¼úÀå CCTV¿¡ ´ëÇÑ Á¤Ã¥ ¼¼¼ÇÀ» ÅëÇÏ¿© ÀÇ·á Á¤Ã¥ÀÌ ÇâÈÄ °©»ó¼±ÁúȯÀÇ ÀÓ»ó Áø·á¿¡ ¹ÌÄ¥ ¿µÇâ°ú ÀÌ¿¡ ´ëÇÑ ¹ßÀüÀûÀÎ ÅäÀÇ°¡ À̾îÁ³´Ù.
À̹ø ÇÐȸ¿¡¼´Â ȸ¿øµéÀÇ È°¹ßÇÑ ¿¬±¸ °á°úµµ ¸¹ÀÌ ¹ßÇ¥µÇ¾ú´Ù. ÃÑ 38°³ÀÇ ³í¹®ÀÌ ¹ßÇ¥µÇ¾úÀ¸¸ç ¿¬±¸Àڵ鿡 ´ëÇÑ ½Ã»óÀÌ À̾îÁ³´Ù.
±¸ºÐ | ¿¬±¸ Á¦¸ñ | ¼º¸í | ¼Ò¼Ó |
---|---|---|---|
¹ü»êÇмú»ó | ¹æ»ç¼º¿ä¿Àµå Ä¡·á¿Í 2Â÷¾Ï | ÀÌÀçÅ | °æºÏÀÇ´ë ÇÙÀÇÇаú |
Àӻ󿬱¸»ó | Comparison of one-week and two-weeks low iodine diet for adequate preparation of radioactive iodine therapy with recombinant human thyroid-stimulating hormone | ±è°æÁø | °í·ÁÀÇ´ë ³»°ú |
Epidemiology and risk factor of Graves¡¯opthalmopathy: a retrospective multicenter cohort study in Korea | ¼Õ¼¿µ | ÇѾçÀÇ´ë ¸íÁöº´¿ø ³»°ú | |
ÃÖ¿ì¼ö¿¬Á¦»ó | Clinicoradiological characteristics in the differential diagnosis of follicular-patterned lesions of the thyroid: A multicenter cohort study | ÇÏÀºÁÖ | ¾ÆÁÖÀÇ´ë ¿µ»óÀÇÇаú |
Completion thyroidectomy may not be required for papillary thyroid carcinoma with multifocality, extrathyroidal extension, vascular invasion or central lymph node metastasis | °¿¹Àº | Ãæ³²ÀÇ´ë ³»°ú | |
¿ì¼ö¿¬Á¦»ó | Lenvatinib versus sorafenib as a first-line treatment of radioactive iodine-refractory progressive differentiated thyroid carcinoma | ±è¹ÌÁø | ºÎ»êÀÇ´ë ³»°ú |
Surgical outcomes in patients with low-risk papillary thyroid microcarcinoma: Immediate operation versus delayed operation following active surveillance | ȲÇö¿í | ¼¿ïÀÇ´ë ¿Ü°ú | |
Thyroid-dedicated Internally-Cooled Wet Electrode for Benign Thyroid Nodules: Experimental and Clinical Study | Á¤¼Ò¿µ | ¿ï»êÀÇ´ë ¿µ»óÀÇÇаú | |
Surgical outcome of preoperative charcoal and indigocarmine tattoo localization of recurred thyroid cancer | ¼¾ÆÁ¤ | ¼¿ïÀÇ´ë ¿Ü°ú | |
Immunolocalization of ACE2 and TMPRSS2 in thyroid | ¹Ú±âö | ¼º±Õ°üÀÇ´ë À̺ñÀÎÈÄ°ú | |
Different progression mechanism in BRAF-like and RAS-like papillary thyroid carcinoma | ÀÓÁø¼± | Â÷ÀÇ°ú´ë ³»°ú | |
¿ì¼öÆ÷½ºÅÍ»ó | Active surveillance in low-risk papillary thyroid microcarcinomas; a single center experience in Korea | À±ÁöÈñ | Àü³²ÀÇ´ë ³»°ú |
Deep learning-based DNA methylation biomarkers for prediction of lymph node metastases in thyroid cancers | Á¤Âù±Ç | °¡Å縯ÀÇ´ë º´¸®°ú | |
Safety Evaluation of SynchroSeal around the Recurrent Laryngeal Nerve in Porcine Models | ¹Ú´Ù¿ø | °í·ÁÀÇ´ë ¿Ü°ú |